Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is in line with its 5-year average of 95.39%, near the high end of its 5-year range (-20.05%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. In line with its 12-month average of 100.00%.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
100.00%
GROSS MARGIN AVG 3Y
64.25%
GROSS MARGIN AVG 5Y
95.39%
GROSS MARGIN AVG 10Y
43.94%
GROSS MARGIN AVG 15Y
36.09%
GROSS MARGIN AVG 20Y
39.22%
CURRENT VS TTM AVG
0.00%
CURRENT VS 3Y AVG
+55.64%
CURRENT VS 5Y AVG
+4.83%
CURRENT VS 10Y AVG
+127.57%
CURRENT VS 15Y AVG
+177.07%
CURRENT VS 20Y AVG
+154.95%
SECTOR MEDIAN · HEALTHCARE
42.90%
median of 561 covered companies
CURRENT VS SECTOR MEDIAN
+133.10%
vs the sector median at left
Arrowhead Pharmaceuticals, Inc.
Market Cap
$8.56B
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
64.25%
5Y Avg
95.39%
Market Cap
$8.49B
Gross Margin
101.98%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$8.54B
Gross Margin
69.66%
TTM Avg
54.89%
3Y Avg
42.48%
5Y Avg
46.51%
Market Cap
$8.83B
Gross Margin
93.24%
TTM Avg
91.97%
3Y Avg
90.98%
5Y Avg
60.65%
Market Cap
$8.39B
Gross Margin
14.38%
TTM Avg
17.24%
3Y Avg
38.82%
5Y Avg
59.22%
Market Cap
$9.10B
Gross Margin
46.69%
TTM Avg
47.45%
3Y Avg
49.39%
5Y Avg
49.15%
Market Cap
$9.36B
Gross Margin
46.69%
TTM Avg
47.45%
3Y Avg
49.39%
5Y Avg
49.15%
Market Cap
$9.48B
Gross Margin
93.34%
TTM Avg
92.85%
3Y Avg
69.90%
5Y Avg
46.60%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $8.56B | 100.00% | 100.00% | 64.25% | 95.39% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.49B | 101.98% | 100.00% | 100.00% | 100.00% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.54B | 69.66% | 54.89% | 42.48% | 46.51% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.83B | 93.24% | 91.97% | 90.98% | 60.65% |
| Oscar Health, Inc. (OSCR)vs › | $8.39B | 14.38% | 17.24% | 38.82% | 59.22% |
| Insulet Corp. (PODD)vs › | $9.37B | 71.08% | 70.71% | 67.87% | 67.39% |
| Bruker Corporation (BRKRP)vs › | $9.10B | 46.69% | 47.45% | 49.39% | 49.15% |
| Bruker Corporation (BRKR)vs › | $9.36B | 46.69% | 47.45% | 49.39% | 49.15% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.48B | 93.34% | 92.85% | 69.90% | 46.60% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.62B | 84.97% | -824.36% | -1521.85% | -1048.03% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 100.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -20.05% |
| 2023-09-30 | 76.03% |
| 2023-06-30 | 79.30% |
| 2023-03-31 | 98.17% |
| 2022-12-31 | 95.70% |
| 2022-09-30 | 91.58% |
| 2022-06-30 | 91.97% |
| 2022-03-31 | 98.30% |
| 2021-12-31 | 90.62% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 31.71% |
| 2008-03-31 | 45.90% |
| 2007-12-31 | 18.78% |
| 2007-09-30 | 34.87% |
| 2007-06-30 | 44.17% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 95.65% |
| 2003-03-31 | 97.60% |
| 2002-12-31 | 96.75% |
| 2002-09-30 | 96.63% |
